Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · IEX Real-Time Price · USD
1.000
-0.010 (-1.02%)
At close:
Mar 27, 2023, 3:53 PM
0.985
-0.015 (-1.48%)
After-hours:
Mar 27, 2023, 4:00 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 - 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.63 | 18.63 | 17.93 | 18.97 | 16.66 | 12.83 | 9.37 | 13.85 | 13.67 | 15.45 | |
| Revenue Growth (YoY) | -32.21% | 3.91% | -5.49% | 13.88% | 29.89% | 36.89% | -32.37% | 1.36% | -11.55% | 21.25% | |
| Cost of Revenue | 8.64 | 12.07 | 9.81 | 10.09 | 9.35 | 7.16 | 6.72 | 6.57 | 5.27 | 4.71 | |
| Gross Profit | 3.99 | 6.56 | 8.12 | 8.88 | 7.31 | 5.67 | 2.65 | 7.29 | 8.4 | 10.74 | |
| Selling, General & Admin | 9.76 | 9.45 | 14.17 | 18.62 | 19.92 | 17.07 | 15.56 | 12.41 | 11.56 | 11.89 | |
| Research & Development | 0.13 | 0.56 | 1.34 | 1.52 | 1.58 | 1.58 | 1.81 | 1.53 | 2.89 | 2.22 | |
| Other Operating Expenses | -0.15 | -0.14 | -3.57 | 0 | 0.31 | 0 | 0 | 0 | 0 | 0 | |
| Operating Expenses | 9.73 | 9.87 | 11.94 | 20.14 | 21.81 | 18.64 | 17.36 | 13.95 | 14.45 | 14.12 | |
| Operating Income | -5.74 | -3.31 | -3.82 | -11.26 | -14.5 | -12.97 | -14.71 | -6.66 | -6.05 | -3.37 | |
| Interest Expense / Income | 0.01 | -0 | 0.02 | 0.03 | 0.04 | 0 | 0 | 0 | 1.06 | 1.11 | |
| Other Expense / Income | -0.33 | -0.07 | -0.56 | 0.05 | -0.26 | -17.98 | -4.56 | 1.54 | -10.84 | 0.95 | |
| Pretax Income | -5.42 | -3.24 | -3.28 | -11.34 | -14.28 | 5.01 | -10.16 | -8.2 | 3.74 | -5.43 | |
| Income Tax | -0.33 | 0.71 | 0.03 | 0.46 | 0.05 | -4.27 | 0 | 0 | 0 | 0 | |
| Net Income | -5.09 | -3.95 | -3.31 | -11.8 | -14.33 | 9.27 | -10.16 | -8.2 | 3.74 | -5.43 | |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.06 | |
| Net Income Common | -5.09 | -3.95 | -3.31 | -11.8 | -14.33 | 9.27 | -10.16 | -8.2 | 3.74 | -6.49 | |
| Shares Outstanding (Basic) | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | |
| Shares Change | 32.92% | 35.14% | 59.85% | 83.70% | 7.17% | 28.43% | 70.29% | 40.00% | 38.60% | 27.22% | |
| EPS (Basic) | -1.92 | -1.97 | -2.24 | -12.77 | -28.49 | 19.80 | -27.81 | -38.25 | 24.30 | -58.50 | |
| EPS (Diluted) | -1.92 | -1.97 | -2.24 | -12.77 | -28.49 | 19.80 | -27.81 | -38.25 | 24.30 | -58.50 | |
| Free Cash Flow Per Share | -1.65 | -1.78 | -3.25 | -12.79 | -25.10 | -18.24 | -24.88 | -31.84 | -35.27 | 8.07 | |
| Gross Margin | 31.62% | 35.21% | 45.30% | 46.81% | 43.88% | 44.19% | 28.26% | 52.61% | 61.44% | 69.52% | |
| Operating Margin | -45.43% | -17.78% | -21.30% | -59.35% | -87.02% | -101.16% | -157.05% | -48.07% | -44.27% | -21.84% | |
| Profit Margin | -40.28% | -21.20% | -18.45% | -62.19% | -86.01% | 72.31% | -108.46% | -59.21% | 27.33% | -42.02% | |
| Free Cash Flow Margin | -34.72% | -19.09% | -26.76% | -62.29% | -75.80% | -66.75% | -97.03% | -49.32% | -39.46% | 5.78% | |
| Effective Tax Rate | - | - | - | - | - | -85.26% | - | - | - | - | |
| EBITDA | -5.22 | -3.01 | -2.95 | -10.85 | -13.75 | 5.26 | -9.92 | -7.95 | 5.08 | -4.06 | |
| EBITDA Margin | -41.35% | -16.18% | -16.46% | -57.22% | -82.53% | 40.99% | -105.83% | -57.36% | 37.15% | -26.25% | |
| Depreciation & Amortization | 0.19 | 0.23 | 0.31 | 0.45 | 0.49 | 0.25 | 0.24 | 0.25 | 0.28 | 0.27 | |
| EBIT | -5.41 | -3.24 | -3.26 | -11.31 | -14.24 | 5.01 | -10.16 | -8.2 | 4.79 | -4.32 | |
| EBIT Margin | -42.83% | -17.40% | -18.20% | -59.60% | -85.47% | 39.06% | -108.43% | -59.19% | 35.07% | -27.98% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).